본문 바로가기
KERD
논문KCI 등재

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류산부인과학

초록

Objective: The objective of this study was to evaluate the effectiveness of dual trigger, which is a combination of gonadotropinreleasing agonist (GnRH-a) and recombinant human chorionic gonadotropin (hCG) in the final oocyte maturation, in the outcome of intrauterine insemination (IUI). Methods: This retrospective observational study was conducted from January 2016 to October 2018 and involved 639 IUI cycles at the Halim Fertility Center, Indonesia. Controlled ovarian stimulation was performed during IUI cycles. The ovulation triggers were divided into two groups: group I received a combination of GnRH-a and recombinant hCG as a dual trigger, and group II received only recombinant hCG as a single trigger. The baseline characteristics, cycle parameters, and IUI outcomes of both groups were compared. Results: Our study included a total of 639 IUI cycles, 334 were in the dual trigger group and 305 in the single trigger group. The clinical pregnancy rates were significantly higher in the dual trigger group than in the single trigger group (P<0.001). Based on the multivariate analysis, the dual trigger increased the clinical pregnancy rate by 2.524 times than that by the single trigger. Conclusion: Our data showed that the dual trigger combination of GnRH-a and recombinant hCG significantly improves the outcome of intrauterine insemination.

Abstract

Objective: The objective of this study was to evaluate the effectiveness of dual trigger, which is a combination of gonadotropinreleasing agonist (GnRH-a) and recombinant human chorionic gonadotropin (hCG) in the final oocyte maturation, in the outcome of intrauterine insemination (IUI). Methods: This retrospective observational study was conducted from January 2016 to October 2018 and involved 639 IUI cycles at the Halim Fertility Center, Indonesia. Controlled ovarian stimulation was performed during IUI cycles. The ovulation triggers were divided into two groups: group I received a combination of GnRH-a and recombinant hCG as a dual trigger, and group II received only recombinant hCG as a single trigger. The baseline characteristics, cycle parameters, and IUI outcomes of both groups were compared. Results: Our study included a total of 639 IUI cycles, 334 were in the dual trigger group and 305 in the single trigger group. The clinical pregnancy rates were significantly higher in the dual trigger group than in the single trigger group (P<0.001). Based on the multivariate analysis, the dual trigger increased the clinical pregnancy rate by 2.524 times than that by the single trigger. Conclusion: Our data showed that the dual trigger combination of GnRH-a and recombinant hCG significantly improves the outcome of intrauterine insemination.

참고문헌 (25)

  1. Soliman BS, "Pregnancy rate after ovulation triggering with gonadotrophin releasing hormone agonist versus human chorionic gonadotrophin in women undergoing controlled ovarian stimulation", intrauterine insemination, 2014, pp.19, 262~267
  2. Weiss A, "A randomized trial comparing time intervals from HCG trigger to intrauterine insemination for cycles utilizing GnRH antagonists", Syst Biol Reprod Med, 61, pp.44~49 (2015)
  3. Le MT, "GnRH agonist versus hCG trigger in ovulation induction with intrauterine insemination : a randomized controlled trial", Int J Endocrinol (2019)[DOI]
  4. Farag AH, "Triggering ovulation with gonadotropin-releasing hormone agonist versus human chorionic gonadotropin in polycystic ovarian syndrome. A randomized trial", Middle East Fertil Soc J, 20, pp.217~223 (2015)
  5. Lee JI, "Comparison of pregnancy rates by intrauterine insemination after ovulation trigger with endogenous LH surge, GnRH agonist or hCG in stimulated cycles", Clin Exp Reprod Med, 26, pp.389~398 (1999)
  6. Taheripanah R, "Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination : An RCT", Int J Reprod Biomed, 15, pp.351~356 (2017)
  7. Andersen AG, "Time interval from human chorionic gonadotrophin(HCG)injection to follicular rupture", Hum Reprod, 10, pp.3202~3205 (1995)
  8. Lin MH, "Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles", Fertil Steril, 100, pp.1296~1302 (2013)
  9. Griffin D, "Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates", Fertil Steril, 102, pp.405~409 (2014)
  10. Fabris AM, "Dual triggering with gonadotropinreleasing hormone agonist and standard dose human chorionic gonadotropin in patients with a high immature oocyte rate", Reprod Sci, 24, pp.1221~1225 (2017)
  11. Mahajan N, "Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates : a prospective randomized study", J Hum Reprod Sci, 9, pp.101~106 (2016)
  12. Zhang J, "Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF", ICSI cycles, 2017, pp.35, 701~707
  13. Li S, "Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols", Oncotarget, 9, pp.5337~5343 (2018)
  14. Chen CH, "Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF", ICSI outcome in GnRH antagonist cycles : a systematic review and meta-analysis, 2018, pp.298, 17~26
  15. Ding N, "Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization : a systematic review and meta-analysis", Eur J Obstet Gynecol Reprod Biol, 218, pp.92~98 (2017)
  16. Kol S, "GnRH agonist triggering : recent developments", Reprod Biomed Online, 26, pp.226~230 (2013)
  17. Youssef MA, "Gonadotropinreleasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology", Cochrane Database Syst Rev, (10), pp.CD008046~ (2014)
  18. Orvieto R, "Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?", J Ovarian Res, 8, pp.60~ (2015)
  19. Humaidan P, "GnRH agonist(buserelin)or hCG for ovulation induction in GnRH antagonist IVF", ICSI cycles : a prospective randomized study, 2005, pp.20, 1213~1220
  20. Viviane Margareth Scantamburlo, "Association between decreased ovarian reserve and poor oocyte quality", Obstetrics & Gynecology Science, 64(6), pp.532~539 (2021), 대한산부인과학회
  21. Haas J, "Co-administration of GnRH-agonist and hCG for final oocyte maturation(double trigger)in patients with low number of oocytes retrieved per number of preovulatory follicles--a preliminary report", J Ovarian Res, 7, pp.77~ (2014)
  22. Zilberberg E, "Co-administration of GnRH-agonist and hCG, for final oocyte maturation(double trigger), in patients with low proportion of mature oocytes", Gynecol Endocrinol, 31, pp.145~147 (2015)
  23. Alyasin A, "GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF", ICSI cycles : a review article, 2016, pp.14, 557~566
  24. Conghui Liu, "The clinical outcomes of fresh versus frozen embryos transfer in women ≥40 years with poor ovarian response", Obstetrics & Gynecology Science, 64(3), pp.284~292 (2021), 대한산부인과학회[DOI]
  25. AboulGheit S, "Pregnancy rates following three different timings of intrauterine insemination for women with unexplained infertility : a randomised controlled trial", Middle East Fertil Soc J, 15, pp.265~268 (2010)

관련 논문AI추천

Association between different dual trigger dosages and in vitro fertilization results in patients with patientoriented strategies encompassing individualized oocyte number group IV강민경, 김민경, 김지원, 김진영, 김태형, 유상우, 이우식, 장은미대한산부인과학회 · Obstetrics & Gynecology Science2022 · 제65권 제2호Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination김석현, 박주현, 서석교, 윤보현, 이병석, 전승주, 조시현, 최영식연세대학교의과대학 · Yonsei Medical Journal2015 · 제56권 제2호Effect of trigger day serum luteinising hormone levels on the in-vitro fertilization outcome: an observational studyGautham T Pranesh, Harpreet Kaur, Kamini A Rao, Vyshnavi Rao대한산부인과학회 · Obstetrics & Gynecology Science2024 · 제67권 제2호Human chorionic gonadotropin-administered natural cycle versus spontaneous ovulatory cycle in patients undergoing two pronuclear zygote frozen-thawed embryo transfer강병문, 김도영, 김성훈, 김정훈, 안준우, 이유정, 채희동대한산부인과학회 · Obstetrics & Gynecology Science2018 · 제61권 제2호Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization김민정, 양광문, 이현정, 이화정, 차선화, 최현정대한산부인과학회 · Obstetrics & Gynecology Science2018 · 제61권 제1호The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization강병문, 권수경, 김성훈, 김정훈, 석혜진, 이경희, 이유정, 채희동대한산부인과학회 · Obstetrics & Gynecology Science2014 · 제57권 제03호

이 간행물의 다른 논문 (12건)